Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1972)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$543.03
Total Value
$130.33K
Shares Held After
41,816
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,797
Price
$542.40
Total Value
$974.69K
Shares Held After
42,056
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,671
Price
$541.23
Total Value
$904.39K
Shares Held After
43,853
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,154
Price
$540.46
Total Value
$1.70M
Shares Held After
45,524
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
535
Price
$539.24
Total Value
$288.49K
Shares Held After
48,678
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$538.43
Total Value
$215.91K
Shares Held After
49,213
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$537.40
Total Value
$214.42K
Shares Held After
49,614
% of Holdings
0.8%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
975
Price
$1.14
Total Value
$1.11K
Shares Held After
135,975
% of Holdings
0.7%
UFP TECHNOLOGIES INC (UFPT)
FELDMANN CYNTHIA L — Director
Shares
100
Price
$240.40
Total Value
$24.04K
Shares Held After
5,476
% of Holdings
1.8%
UFP TECHNOLOGIES INC (UFPT)
FELDMANN CYNTHIA L — Director
Shares
1,100
Price
$239.19
Total Value
$263.11K
Shares Held After
5,576
% of Holdings
16.5%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
5,000
Price
$1.77
Total Value
$8.85K
Shares Held After
10,100
% of Holdings
49.5%
Tonix Pharmaceuticals Holding Corp. (TNXP)
Taylor Carolyn E. — Director
Shares
1,415
Price
$10.55
Total Value
$14.93K
Shares Held After
1,833
% of Holdings
77.2%
ARS Pharmaceuticals, Inc. (SPRY)
Karas Eric — Chief Commercial Officer
Shares
25,000
Price
$10.00
Total Value
$250.00K
Shares Held After
12,176
% of Holdings
67.2%
ARS Pharmaceuticals, Inc. (SPRY)
Fitzpatrick Alexander A — Chief Legal Officer
Shares
3,355
Price
$10.00
Total Value
$33.55K
Shares Held After
90,910
% of Holdings
3.6%
Alkermes plc. (ALKS)
Wright Christopher I — Director
Shares
2,000
Price
$45.10
Total Value
$90.20K
Shares Held After
25,680
% of Holdings
7.2%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP & Chief Mfg and Supply Cha
Shares
25
Price
$414.13
Total Value
$10.35K
Shares Held After
1,406
% of Holdings
1.7%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
12,583
Price
$70.11
Total Value
$882.18K
Shares Held After
38,743
% of Holdings
24.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,349
Price
$23.93
Total Value
$151.90K
Shares Held After
63,443
% of Holdings
9.1%
Warby Parker Inc. (WRBY)
Moon Youngme E — Director
Shares
10,000
Price
$26.53
Total Value
$265.30K
Shares Held After
26,061
% of Holdings
27.7%
Syndax Pharmaceuticals Inc (SNDX)
Botwood Nicholas A.J. — Head of R&D, CMO
Shares
31,235
Price
$18.14
Total Value
$566.60K
Shares Held After
60,885
% of Holdings
33.9%
Summit Therapeutics Inc. (SMMT)
Zanganeh Mahkam — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Summit Therapeutics Inc. (SMMT)
DUGGAN ROBERT W — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Kalif Eliyahu Sharon — EVP, Chief Financial Officer
Shares
106,563
Price
$34.10
Total Value
$3.63M
Shares Held After
65,621
% of Holdings
61.9%
111, Inc. (YI)
Sun Jian David — Director
Shares
111,100
Price
$0.23
Total Value
$25.55K
Shares Held After
472,011
% of Holdings
19.1%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
1,462
Price
$4.12
Total Value
$6.02K
Shares Held After
149,377
% of Holdings
1.0%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
15
Price
$0.01
Total Value
$0.15
Shares Held After
49
% of Holdings
23.4%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
3
Price
$0.01
Total Value
$0.03
Shares Held After
64
% of Holdings
4.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.01
Total Value
$0.01
Shares Held After
61
% of Holdings
1.6%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.01
Total Value
$0.01
Shares Held After
60
% of Holdings
1.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.02
Total Value
$0.02
Shares Held After
59
% of Holdings
1.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.02
Total Value
$0.02
Shares Held After
58
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
5,000
Price
$19.00
Total Value
$95.00K
Shares Held After
411,775
% of Holdings
1.2%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
756
Price
$261.00
Total Value
$197.32K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
428
Price
$257.63
Total Value
$110.27K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
149
Price
$258.81
Total Value
$38.56K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
200
Price
$258.28
Total Value
$51.66K
Shares Held After
149
% of Holdings
57.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
859
Price
$257.59
Total Value
$221.27K
Shares Held After
349
% of Holdings
71.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
741
Price
$256.23
Total Value
$189.87K
Shares Held After
1,208
% of Holdings
38.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
626
Price
$261.20
Total Value
$163.51K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
120
Price
$257.53
Total Value
$30.90K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
49
Price
$256.39
Total Value
$12.56K
Shares Held After
120
% of Holdings
29.0%
BeOne Medicines Ltd. (ONC)
Rosenberg Aaron — Chief Financial Officer
Shares
631
Price
$257.74
Total Value
$162.64K
Shares Held After
0
% of Holdings
100.0%
Guardant Health, Inc. (GH)
Kalia Kumud — Chief Information Officer
Shares
3,418
Price
$130.24
Total Value
$445.16K
Shares Held After
41,090
% of Holdings
7.7%
Corvus Pharmaceuticals, Inc. (CRVS)
Moore David Scott — Director
Shares
21,700
Price
$11.53
Total Value
$250.24K
Shares Held After
21,700
% of Holdings
100.0%
American Well Corp (AMWL)
Schlegel Stephen J. — Director
Shares
9,750
Price
$8.76
Total Value
$85.45K
Shares Held After
54,553
% of Holdings
15.2%
Pelthos Therapeutics Inc. (PTHS)
Davis Todd C — Director
Shares
503
Price
$28.73
Total Value
$14.45K
Shares Held After
75,834
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Davis Todd C — Director
Shares
35,445
Price
$27.80
Total Value
$985.53K
Shares Held After
75,331
% of Holdings
47.1%
Keros Therapeutics, Inc. (KROS)
Newton Charles W. — Director
Shares
550
Price
$10.04
Total Value
$5.52K
Shares Held After
12,665
% of Holdings
4.2%
CervoMed Inc. (CRVO)
BOGER JOSHUA S — Director
Shares
955,414
Price
$3.14
Total Value
$3.00M
Shares Held After
1,795,865
% of Holdings
53.2%
NEXGEL, INC. (NXGL)
Levy Adam R. — Director
Shares
3,000
Price
$0.61
Total Value
$1.84K
Shares Held After
333,692
% of Holdings
0.9%
Showing 301–350 of 1972 transactions (page 7 of 40)